UPC CoA 153/2026

Sep 15, 2026·EP3167888 Unitary patent · TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT

Case details: Status
Written Phase
Action
Appeal
Category
File-access requests (R. 262.1(b))
Parties: Claimants
Carpmaels & Ransford LLP
Representatives
Agathe Michel-De Cazotte-Carpmaels & Ransford
Respondents
Amgen Zdravila D.O.O.Operating co.
Amgen Biofarmacêutica Lda.Operating co.
Amgen S.R.L.Operating co.
Amgen S.A.S.Operating co.
Amgen ABOperating co.
Amgen GmbHOperating co.
Amgen NVOperating co.
Amgen Technology (Ireland) Unlimited CompanyOperating co.
Alexion Pharmaceuticals, Inc.Operating co.
Representatives
Tilman Mueller-Stoy-Bardehle Pagenberg
Elena Hennecke-Freshfields
Division: Court of Appeal
Judges: Rian Kalden
Patricia Rombach
Ingeborg Simonsson
Technology: Chemistry
Biotechnology · Pharmaceuticals
Language: English
EPO Opposition: Samsung Bioepis NL B.V.Withdrawn2024-05-02
Amgen Technology (Ireland) Unlimited CompanyWithdrawn2024-10-28
Salute HC Ilaç Pazarlama A.S.Admissible2025-01-31

How this compares

How long the court takes to reach a first decision.

	Median days to first decision
All UPC	124
Judge Rian Kalden	Locked
Judge Patricia Rombach	Locked
Judge Ingeborg Simonsson	Locked

Related cases

Documents

Document title	Date	Public
Receipt	2026-09-30	Not public
Cover sheet	2026-09-30	Not public
Exhibit Defendant/Respondent	2026-09-30	Not public
Exhibit Defendant/Respondent	2026-09-30	Not public
Submission Defendant/Respondent	2026-09-30	Not public
Receipt	2026-09-30	Not public
Cover sheet	2026-09-30	Not public
Submission Defendant/Respondent	2026-09-30	Not public
Order	2026-09-23	Not public
Order	2026-09-23	Public